ozempic novo nordisk - Search News

Order byBest matchMost fresh

Novo Nordisk, Ozempic

Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash

“Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,” GoodRx CEO and President Wendy Barnes said in a statement.

· 11h

Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients

· 3h

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

· 14h

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

Canada has approved Novo Nordisk's (NOVOb.CO) diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in type-2 diabetes patien...

· 13h

GLP-1 drug Ozempic is now half the price for patients – on one condition

· 1d

Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs

· 15h

Novo Nordisk Slashes Price of Ozempic for Out-of-Pocket Users

The drugmaker says patients who pay for the medication on their own and don’t go through insurance can get monthly supplies for $499.

· 1d

Novo Nordisk to offer Ozempic at $499 per month to eligible US customers

· 1d

Health Care Flat as Beaten-Down Stocks Rebound -- Health Care Roundup

10h

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

10h

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official website.

REVOLT on MSN9h

Ozempic reportedly faces $2 billion in lawsuits over severe side effects

Over 1,800 lawsuits claim Ozempic caused stomach paralysis, vision loss, and more. Read what’s next in the legal fight.

Gynaecologist explains little-known side effects as women detail their experiences of 'Ozempic vulva'

Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.

BioSpace6d

A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall

Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma recover?

HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost

Novo Nordisk A/S (NYSE:NVO) is one of the best falling stocks to buy now. On August 7, HSBC maintained a “Hold” rating on Novo Nordisk and lifted the price target to 355 Danish Krone (DKK) from DKK340.

Novo Nordisk, Ozempic

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

Ozempic reportedly faces $2 billion in lawsuits over severe side effects

Gynaecologist explains little-known side effects as women detail their experiences of 'Ozempic vulva'

A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall

HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost

Related topics